Masaryk University Technology Transfer Office prepared an interview with Vitezslav Bryja about developing inhibitors of casein kinase 1 in collaboration with Kamil Paruch´s group (Department of Chemistry) that can be used in the future as treatment of chronic lymphocytic leukemia and potentially also of other diseases.
Read the interview here: https://www.ctt.muni.cz/en/news/interface/articles/i-peeked-into-a-world-that-was-hidden-to-me-says-vitezslav-bryja
Abstract: The choroid plexus (ChP) produces cerebrospinal fluid and forms an essential brain barrier. ChP... Read More
Research group of Assoc. Prof. Pavel Hyršl continues with the collection of bees within research... Read More
Students from the Laboratory of Molecular Morphogenesis led by assoc. prof. Marcela Buchtová prepared an... Read More
Při příležitosti pátého ročníku Business research fóra, veletrhu vyzdvihujícího spolupráci mezi akademickým a soukromým sektorem a zejména... Read More
V minulých dnech proběhly v prostorách OFIŽ dvě přednášky a cvičení z cyklu T-exkurzí. Jedná... Read More
Bryjalab continues in the development of methods for the analysis of exosomes: After flow cytometry... Read More